Antifibrinolytic therapy during OPCAB surgery: A word of caution [2]

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 3, 2002, Pages 391-392

  Donias, Harry W ^a   Karamanoukian, Raffy L ^a   Karamanoukian, Hratch L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; D DIMER; PROTAMINE; HEPARIN;

BLEEDING; BLOOD CLOTTING TIME; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE CONCENTRATE; HUMAN; LETTER; PRIORITY JOURNAL; THROMBOSIS; TRANSFUSION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; METHODOLOGY;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; HEPARIN; HUMANS;

EID: 0036017644     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.124158     Document Type: Letter

References (7)

1. Procoagulant activity after off-pump coronary operations: Is the current anticoagulation adequate?
2. Tranexamic acid in off-pump coronary surgery: A preliminary, randomized, double-blind, placebo-controlled study
3. The use of blood products in off-pump coronary artery bypass grafting
4. OPCAB (Off Pump Clopidogrel Aspirin or Both) therapy survey
5. OPCAB in reoperative myocardial revascularization: Intermediate-term outcomes
6. The role of coronary graft flow measurement during reoperations for early graft failure following off-pump coronary revascularization
7. Graft revision after transit time flow measurement in off-pump coronary artery bypass grafting